Management complexities of HIV/hepatitis C virus coinfection in the twenty-first century.

Abstract:

:Because of shared routes of transmission, hepatitis C virus (HCV) coinfection is common among HIV-infected persons. Because of the effectiveness of antiretroviral therapy, chronic HCV has now emerged as a major cause of morbidity and mortality in this population. Because chronic HCV is highly prevalent among HIV-infected patients and has a rapid disease progression, antiviral therapy with pegylated interferon plus ribavirin is critical for the long-term survival of HIV/HCV-coinfected patients. In this article, the authors review the (1) epidemiology of HCV among HIV-infected individuals, (2) effect of HIV on the natural history of chronic HCV, (3) impact of antiretroviral therapy on HCV coinfection, and (4) management of chronic HCV in the HIV-infected person.

journal_name

Clin Liver Dis

journal_title

Clinics in liver disease

authors

Lo Re V 3rd,Kostman JR,Amorosa VK

doi

10.1016/j.cld.2008.03.009

subject

Has Abstract

pub_date

2008-08-01 00:00:00

pages

587-609, ix

issue

3

eissn

1089-3261

issn

1557-8224

pii

S1089-3261(08)00034-2

journal_volume

12

pub_type

杂志文章,评审
  • Artificial liver support devices for fulminant liver failure.

    abstract::Artificial liver-support devices attempt to bridge patients with fulminant hepatic failure until either a suitable liver allograft is obtained for transplantation or the patient's own liver regenerates sufficiently to resume normal function. It is thought that toxins contribute to the clinical picture of fulminant hep...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/s1089-3261(05)70172-0

    authors: Sechser A,Osorio J,Freise C,Osorio RW

    更新日期:2001-05-01 00:00:00

  • Management of autoimmune and cholestatic liver disorders.

    abstract::The management of autoimmune and cholestatic liver disorders is a challenging area of hepatology. Autoimmune and cholestatic liver diseases represent a comparatively small proportion of hepatobiliary disorders, yet their appropriate management is of critical importance for patient survival. In this article, management...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章

    doi:10.1016/j.cld.2009.02.011

    authors: Krok KL,Munoz SJ

    更新日期:2009-05-01 00:00:00

  • Understanding and Treating Pruritus in Primary Biliary Cholangitis.

    abstract::Pruritus is a common symptom with primary biliary cholangitis. Research has focused on refining understanding of the neurohumoral pathways involved in transduction of pruritus from peripheral cutaneous receptors to the central nervous system, and identifying modulating drugs. Current treatments have variable efficacy ...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2018.03.005

    authors: Carrion AF,Rosen JD,Levy C

    更新日期:2018-08-01 00:00:00

  • Autoimmune Hepatitis in the Liver Transplant Graft.

    abstract::Recurrent autoimmune hepatitis (AIH) and de novo AIH are 2 important causes of late graft failure after liver transplantation (LT). Recurrent AIH occurs in patients who undergo LT for AIH. De novo AIH occurs in patients who are transplanted for etiologies other than AIH. Although typically treated with standard treatm...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2016.12.010

    authors: Beal EW,Black SM,Michaels A

    更新日期:2017-05-01 00:00:00

  • Endoscopic retrograde cholangiopancreatography in diagnosis and treatment of primary sclerosing cholangitis.

    abstract::Primary sclerosing cholangitis is characterized by progressive fibrosing obliteration of the biliary tract. In some cases the disease is restricted to the small bile ducts, but most patients develop fibrotic stenoses of the larger bile ducts. Despite advances in magnetic resonance cholangiography, in unclear cases end...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2010.03.010

    authors: Gotthardt D,Stiehl A

    更新日期:2010-05-01 00:00:00

  • Molecular virology of the hepatitis C virus: implication for novel therapies.

    abstract::The study of hepatitis C virus (HCV) molecular virology is helping to shape the future of our anti-HCV strategies by identifying new antiviral targets. With the advent of agents that specifically target individual HCV proteins, HCV-specific therapy has arrived. Key to these efforts is the development of high-efficienc...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2005.05.013

    authors: Glenn JS

    更新日期:2005-08-01 00:00:00

  • The Management of Hepatitis B in Liver Transplant Recipients.

    abstract::Liver transplant (LT) is now an established indication for patients with chronic hepatitis B, mainly because of the development and use of hepatitis B immunoglobulin (HBIG) and oral antivirals for prophylaxis. The combination of low-dose HBIG and antivirals has been considered the standard prophylaxis regimen to preve...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2016.06.004

    authors: Saab S,Chen PY,Saab CE,Tong MJ

    更新日期:2016-11-01 00:00:00

  • Legal Responsibilities of Physicians When They Diagnose Hepatic Encephalopathy.

    abstract::Both covert hepatic encephalopathy (CHE) and overt hepatic encephalopathy (OHE) impair the ability to operate machinery. The legal responsibilities of US physicians who diagnose and treat patients with hepatic encephalopathy vary among states. It is imperative that physicians know the laws regarding reporting in their...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2015.04.004

    authors: Vierling JM

    更新日期:2015-08-01 00:00:00

  • Capsule endoscopy in portal hypertension.

    abstract::Since the introduction of small bowel capsule endoscopy, and more recently of esophageal capsule endoscopy, these diagnostic tools have become available for the evaluation of the consequences of portal hypertension in the esophagus, stomach, and small intestine. The main advantage of the esophageal and the small bowel...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2010.03.004

    authors: Rondonotti E,Villa F,Dell' Era A,Tontini GE,de Franchis R

    更新日期:2010-05-01 00:00:00

  • Liver transplantation for hepatocellular carcinoma: expanding frontiers and building bridges.

    abstract::Despite significant advances in nonsurgical treatments of hepatocellular carcinoma, these approaches rarely result in cure. Surgery remains the mainstay of curative therapy for hepatocellular carcinoma. Liver transplantation, in particular, has emerged as one of the most beneficial therapeutic modalities. Questions re...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章

    doi:10.1016/j.cld.2011.03.005

    authors: Masuoka HC,Rosen CB

    更新日期:2011-05-01 00:00:00

  • The international normalized ratio of prothrombin time in the model for end-stage liver disease score: a reliable measure.

    abstract::The Model for End-stage Liver Disease (MELD) has been demonstrated to be an excellent predictor of survival in patients who have end-stage liver disease. It is derived from the international normalized ratio (INR) of prothrombin time, serum creatinine, and serum total bilirubin. The major use of the MELD score is to p...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章

    doi:10.1016/j.cld.2008.09.001

    authors: Kamath PS,Kim WR

    更新日期:2009-02-01 00:00:00

  • New Thoughts on Immunoglobulin G4-Related Sclerosing Cholangitis.

    abstract::Immunoglobulin G4 (IgG4)-related sclerosing cholangitis (IgG4-SC) is the biliary manifestation of the multisystem IgG4-related disease. IgG4-SC presents with biliary strictures and/or masses that can bear a striking similarity to other malignant and inflammatory diseases. Diagnosis is based on a combination of clinica...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2015.08.004

    authors: Smit WL,Culver EL,Chapman RW

    更新日期:2016-02-01 00:00:00

  • Chronic hepatitis B: past, present, and future.

    abstract::There have been major advances in the field of hepatitis B (HBV) over the last few decades. These advances have resulted in the understanding of the natural history of chronic HBV infection, effective vaccines against the virus, sensitive assays for screening and monitoring of treatment, and effective treatments for v...

    journal_title:Clinics in liver disease

    pub_type: 历史文章,杂志文章,评审

    doi:10.1016/j.cld.2010.05.003

    authors: Lai M,Liaw YF

    更新日期:2010-08-01 00:00:00

  • Nonsteroidal anti-inflammatory drug-induced hepatotoxicity.

    abstract::Nonsteroidal anti-inflammatory drugs are among the most common drugs associated with drug-induced liver injury, with an estimated incidence of between 3 and 23 per 100,000 patient years. Nimesulide, sulindac, and diclofenac seem to be associated with the highest risk and the only risk factor consistently identified is...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2007.06.004

    authors: Aithal GP,Day CP

    更新日期:2007-08-01 00:00:00

  • Liver abnormalities in rheumatic diseases.

    abstract::Abnormalities of LFTs and liver function occur not infrequently in patients with rheumatic conditions, and many diagnostic possibilities exist. Systemic inflammation that is related to uncontrolled rheumatic disease and periods of disease remission have been described as a cause for fluctuations in levels of serum ami...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/s1089-3261(02)00052-1

    authors: Walker NJ,Zurier RB

    更新日期:2002-11-01 00:00:00

  • Pediatric liver transplantation.

    abstract::In the past two decades, pediatric liver transplantation has become the state-of-the-art operation with anticipated success and limited mortality. The future success of pediatric liver transplantation will require thoughtful solutions to the delicate balance of risk to donors and recipients, the complex needs of the a...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2005.10.004

    authors: Tiao G,Ryckman FC

    更新日期:2006-02-01 00:00:00

  • New Methods of Testing and Brain Imaging in Hepatic Encephalopathy: A Review.

    abstract::The diagnosis of hepatic encephalopathy is predominantly clinical, and the tests available assist in the diagnosis only by excluding other causes. Covert hepatic encephalopathy, which is defined as abnormal performance on psychometric tests when standard neurologic examination is completely normal, has gained widespre...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2015.04.001

    authors: Edula RG,Pyrsopoulos NT

    更新日期:2015-08-01 00:00:00

  • Nonviral or Drug-Induced Etiologies of Acute Liver Failure.

    abstract::Acute liver failure (ALF) is a rare but highly fatal condition. The most common causes include drug-induced and viral hepatitis, but other less common etiologies, especially autoimmune hepatitis, Budd-Chiari syndrome, and Wilson disease, need to be considered. Because diagnosis is frequently tied to potential for reve...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2018.01.008

    authors: Rosenblatt R,Brown RS Jr

    更新日期:2018-05-01 00:00:00

  • Role of Transjugular Intrahepatic Portosystemic Shunt in the Management of Portal Hypertension: Review and Update of the Literature.

    abstract::Transjugular intrahepatic portosystemic shunt (TIPS) is a well-established procedure used in the management of complications of portal hypertension. Although the most robust evidence supports the use of TIPS as salvage therapy in variceal hemorrhage, secondary prophylaxis of variceal bleeding, and treatment of refract...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2019.07.004

    authors: Hung ML,Lee EW

    更新日期:2019-11-01 00:00:00

  • Mechanisms of ascites formation.

    abstract::Ascites is the most common complication of cirrhosis. It is associated with profound changes in the splanchnic and systemic circulation and with renal abnormalities. The development of ascites is related to the existence of severe sinusoidal portal hypertension that causes marked splanchnic arterial vasodilation and a...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/s1089-3261(05)70118-5

    authors: Cárdenas A,Bataller R,Arroyo V

    更新日期:2000-05-01 00:00:00

  • Natural history of chronic hepatitis B.

    abstract::In this article, the 4 phases of chronic HBV infection are reviewed and the factors that are associated with disease progression and the development of hepatocellular carcinoma (HCC) and cirrhosis are discussed. Also discussed is what is known to date about how to identify persons at the highest risk of developing HCC...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2010.05.007

    authors: McMahon BJ

    更新日期:2010-08-01 00:00:00

  • Surgery versus transjugular intrahepatic portal systemic shunt in the treatment of severe variceal bleeding.

    abstract::The management of patients who have portal hypertension has changed dramatically over the last 2 decades. Pharmacologic therapy benefits the patient by reducing the risk for an initial bleed, improving the management of an acute bleed, and in reducing the risk for a rebleed. Endoscopic management has improved progress...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2006.08.020

    authors: Henderson JM

    更新日期:2006-08-01 00:00:00

  • Hepatitis C viral kinetics: the past, present, and future.

    abstract::Mathematical modeling of hepatitis C viral kinetics has been an important tool in understanding hepatitis C virus (HCV) infection dynamics and in estimating crucial in vivo parameters characterizing the effectiveness of HCV therapy. Because of the introduction of direct-acting antiviral agents, there is a need to exte...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2012.09.003

    authors: Chatterjee A,Smith PF,Perelson AS

    更新日期:2013-02-01 00:00:00

  • Liver dysfunction and parenteral nutritional therapies.

    abstract::Hepatobiliary dysfunction associated with the use of total parenteral nutrition is a commonly recognized phenomenon occurring in up to 90% of patients on long-term therapy. Reasons for these abnormalities, both supported by research as well as theoretical possibilities are explored. Practical guidelines considered use...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/s1089-3261(05)70368-8

    authors: Porayko MK

    更新日期:1998-02-01 00:00:00

  • Quantitative Systems Toxicology Approaches to Understand and Predict Drug-Induced Liver Injury.

    abstract::The DILI-sim Initiative is a public-private partnership using quantitative systems toxicology to build a model (DILIsym) capable of understanding and predicting liver safety liabilities in drug candidates. The effort has provided insights into mechanisms underlying dose-dependent drug-induced liver injury (DILI) and i...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2019.09.003

    authors: Watkins PB

    更新日期:2020-02-01 00:00:00

  • The natural history of chronic hepatitis C virus infection.

    abstract::In conclusion, the natural history of chronic HCV infection has not yet been fully defined. Current data suggest that the process runs an indolent course during the first two decades after initial infection, accounting for modest morbidity and mortality. Serious sequelae are more likely to emerge as the disease proces...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/s1089-3261(05)70323-8

    authors: Seeff LB

    更新日期:1997-11-01 00:00:00

  • Cholestasis and alcoholic liver disease.

    abstract::Histologic cholestasis and clinical jaundice may be seen in all stages of alcoholic liver disease. In rare cases, isolated cholestasis without significant steatosis, hepatitis, or cirrhosis is identified in an alcoholic patient. The mechanisms of ethanol-induced cholestasis are not well studied but may involve compres...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/s1089-3261(05)70086-6

    authors: Tung BY,Carithers RL Jr

    更新日期:1999-08-01 00:00:00

  • Locoregional therapy of hepatocellular carcinoma.

    abstract::Hepatocellular carcinoma can be treated using minimally invasive, image-guided, catheter-based or percutaneous techniques. Such procedures offer compelling clinical outcomes with a favorable side-effect profile in a population of patients who are poor candidates for surgical or systemic treatment. This article discuss...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2015.01.008

    authors: Habib A,Desai K,Hickey R,Thornburg B,Lewandowski R,Salem R

    更新日期:2015-05-01 00:00:00

  • The Liver in Sickle Cell Disease.

    abstract::Patients with sickle cell disease can develop liver disease as a result of intrahepatic sickling of erythrocytes, viral hepatitis and iron overload secondary to multiple blood transfusions, and gallstone disease as a result of chronic hemolysis. The spectrum of clinical liver disease is wide and often multifactorial. ...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2018.12.002

    authors: Theocharidou E,Suddle AR

    更新日期:2019-05-01 00:00:00

  • Health care-associated transmission of hepatitis B and C viruses in endoscopy units.

    abstract::The risk for potential transmission of infectious agents during gastrointestinal (GI) endoscopy is concerning for patients and physicians. However, the instance of infection transmission remains rare after GI endoscopy procedures, with an estimated frequency of 1 in 1.8 million procedures. Endoscopy-related infection ...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2009.11.012

    authors: Wu H,Shen B

    更新日期:2010-02-01 00:00:00